Description：

Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

Chemical Information：

Molecular Weight (MW)		553.59
Formula		C30H28FN7O3
CAS No.		1020172-07-9
Solubility (25°C) *	DMSO	111 mg/mL (200.5 mM)
	Water	Insoluble
	Alcohol	16 mg/mL (28.9 mM)

Preparing Stock Solutions

Concentration Volume (DMSO) Mass	1 mg	5 mg	10 mg
1 mM	1.8064 mL	9.0320 mL	18.0639 mL
5 mM	0.3613 mL	1.8064 mL	3.6128 mL
10 mM	0.1806 mL	0.9032 mL	1.8064 mL
50 mM	0.0361 mL	0.1806 mL	0.3613 mL

Bought notes(bought amounts latest0)

No one bought this product

Total 0 records, divided into1 pages. First Prev Next Last